Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating adverse events and changes in disease activity of oral Icalcaprant in adults with bipolar I or II disorder. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Bipolar Ii Disorder

Drugs mentioned

• Icalcaprant (icalcaprant)

Snippet

Sponsor: AbbVie | Conditions: Bipolar I Disorder, Bipolar II Disorder | Phase 2 | Status: RECRUITING